利凡诺联合米非司酮用于瘢痕子宫中孕引产的临床疗效分析

To Observe the Clinical Efficacy of Rivanol Combined with Mifepristone for Uterine Scar Pregnancy

目的探究利凡诺联合米非司酮应用于瘢痕子宫中孕引产的临床疗效。方法选取该院2011年8月—2016年2月自愿要求引产的瘢痕子宫孕妇50例,将其随机分为对照组(25例)和观察组(25例),分别采取单一利凡诺和利凡诺联合米非司酮引产,比较两组产妇的宫缩出现时间、引产时间、总产程、产后出血量、引产成功率以及并发症发生率。结果观察组孕妇的宫缩出现时间为(19.64±2.15)h、引产时间为(15.22±3.17)h、总产程为(7.16±1.32)h、产后出血量为(112.57±11.56)m L,而对照组孕妇的宫缩出现时间、引产时间、总产程和产后出血量分别为(29.33±3.11)h、(24.55±4.76)h、(11.59±1.97)h和(231.68±12.48)m L,观察组孕妇以上数据与对照组对比,差异有统计学意义(P<0.05)。观察组产妇的引产成功率和并发症发生率分别为96.00%和4.00%,而对照组产妇的引产成功率和并发症发生率分别为76.00%和28.00%,与对照组孕妇对比,观察组孕妇的引产成功率明显更改,并发症发生率更低,差异有统计学意义(P<0.05)。结论利凡诺联合米非司酮应用于瘢痕子宫中孕引产能够提高引产成功率、缩短其分娩时间、减少产后出血量,并且可降低孕妇的并发症发生率。

Objective To explore clinical efficacy of rivanol combined with mifepristone for uterine scar pregnancy.Methods 50 cases of scar uterus pregnant women in our hospital from August 2011 to February 2016 were selected,randomly divided for control group（25 cases） and observation group（25 cases）, respectively, to take a single rivanol and rivanol mifepristone for induction, Contractions were compared between the two groups of puerperas appear time,induction time, total labor, postpartum hemorrhage volume, and the success rate of abortion and the incidence of complications. Results The observation group of pregnant women, uterine appear time（19.64±2.15）h, the induction time（15.22±3.17）h, the total production process for（7.16±1.32）h, the amount of postpartum hemorrhage for（112.57±11.56） m L,while the control group of pregnant women, uterine contraction time, induction time, total production of labor and postpartum bleeding were（29.33±3.11）h,（24.55±4.76）h,（11.59±1.97）h and（231.68±12.48）m L and observation group of pregnant women, the above data and compared with the control group, both have obvious advantages（P〈0.05）. To observe the occurrence of group, maternal induction success rate and complication rate was 96% and 4.00%respectively, while the control group, maternal induction success rate and complication occurrence rate was 76.00% and 28.0% respectively, and pregnant women in the control group comparison, observation group of pregnant women,abortion success rate was significantly changed, lower incidence of complications, significant difference（P〈0.05）.Conclusion Rivanol combined with mifepristone on uterine scar pregnancy can improve the abortion success rate,shorten the delivery time, reduce the incidence of postpartum hemorrhage, and can reduce the incidence of complications in pregnant women.